Literature DB >> 15618668

Genetic polymorphism of human cytochrome p450 involved in drug metabolism.

Kiyoshi Nagata1, Yasushi Yamazoe.   

Abstract

Recent advances in human gene analysis promoted by the human genome project have brought us a massive amount of information. These data can be seen and analyzed by personal computer through individual Web sites. As a result, the best use of bioinformatic is essential for recent molecular biology research. Genetic polymorphism of drug-metabolizing enzymes influences individual drug efficacy and safety through the alteration of pharmacokinetics and disposition of drugs. Considerable amounts of data have now accumulated as allelic differences of various drug metabolizing enzymes. Current understanding of genotype information on cytochrome P450 is hereby summarized, based on the Web site for their use in individual optimization of drug therapy.

Entities:  

Year:  2002        PMID: 15618668     DOI: 10.2133/dmpk.17.167

Source DB:  PubMed          Journal:  Drug Metab Pharmacokinet        ISSN: 1347-4367            Impact factor:   3.614


  6 in total

1.  Influence of CYP2D6 and CYP2C19 genetic polymorphism on the pharmacokinetics of tolperisone in healthy volunteers.

Authors:  M Pawlowska; M Bogiel; J Duda; E Sieradzki
Journal:  Eur J Clin Pharmacol       Date:  2015-05-09       Impact factor: 2.953

2.  The high prevalence of the poor and ultrarapid metabolite alleles of CYP2D6, CYP2C9, CYP2C19, CYP3A4, and CYP3A5 in Taiwanese population.

Authors:  Ya-Huei Liou; Chien-Ting Lin; Ying-Jye Wu; Lawrence Shih-Hsin Wu
Journal:  J Hum Genet       Date:  2006-08-19       Impact factor: 3.172

3.  In vitro cytochrome P450-mediated metabolism of exemestane.

Authors:  Landry K Kamdem; David A Flockhart; Zeruesenay Desta
Journal:  Drug Metab Dispos       Date:  2010-09-28       Impact factor: 3.922

4.  Hepatic CYP3A expression is attenuated in obese mice fed a high-fat diet.

Authors:  Kouichi Yoshinari; Shunsuke Takagi; Teruyasu Yoshimasa; Junko Sugatani; Masao Miwa
Journal:  Pharm Res       Date:  2006-05-25       Impact factor: 4.200

5.  Study of the pharmacokinetic changes of Tramadol in diabetic rats.

Authors:  Hoda Lavasani; Behjat Sheikholeslami; Yalda H Ardakani; Mohammad Abdollahi; Lida Hakemi; Mohammad-Reza Rouini
Journal:  Daru       Date:  2013-03-07       Impact factor: 3.117

6.  Prenatal Exposure to Gutkha, a Globally Relevant Smokeless Tobacco Product, Induces Hepatic Changes in Adult Mice.

Authors:  Shannon Doherty Lyons; Jason L Blum; Carol Hoffman-Budde; Pamela B Tijerina; M Isabel Fiel; Daniel J Conklin; Francesca Gany; Joseph A Odin; Judith T Zelikoff
Journal:  Int J Environ Res Public Health       Date:  2020-10-28       Impact factor: 4.614

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.